Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 4 |
Netflix
NFLX
|
+$598M |
| 5 |
Amazon
AMZN
|
+$575M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.46B |
| 2 |
SNDK
Sandisk
SNDK
|
+$1.13B |
| 3 |
Apple
AAPL
|
+$426M |
| 4 |
Linde
LIN
|
+$316M |
| 5 |
Vertiv
VRT
|
+$297M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Healthcare | 14.83% |
| 3 | Consumer Discretionary | 11.24% |
| 4 | Industrials | 10.49% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
PharmaCyte Biotech
PMCB
$5.25M
| $29.3K | ﹤0.01% |
37,987
-18,513
| -33% | -$13.9K |
|
|
CGC
3077
Canopy Growth
CGC
$434M
| $29K | ﹤0.01% |
+30,500
| New | +$32.4K |
|
|
PMI
3078
Picard Medical
PMI
$8.85M
| $28.2K | ﹤0.01% |
+3,448
| New | +$73.3K |
|
|
RKLZ
3079
Defiance Daily Target 2x Short RKLB ETF
RKLZ
$4.5M
| $27.5K | ﹤0.01% |
+10,900
| New | +$88.9K |
|
|
SDEV
3080
Stablecoin Development Corp
SDEV
$44M
| $27.4K | ﹤0.01% |
26,142
-56,653
| -68% | -$78.1K |
|
3081
LivePerson
LPSN
| $26.8K | ﹤0.01% |
+14,111
| New | +$33.9K |
|
3082
Stereotaxis
STXS
$130M
| $26.5K | ﹤0.01% |
15,400
-357,200
| -96% | -$671K |
|
3083
TROOPS Inc
TROO
$257M
| $25.8K | ﹤0.01% |
+10,500
| New | +$33.1K |
|
|
KNDI
3084
Kandi Technologies Group
KNDI
$62M
| $25.8K | ﹤0.01% |
36,100
-31,600
| -47% | -$23.3K |
|
3085
CBAK Energy Technology Ltd
CBAT
$88.6M
| $24.5K | ﹤0.01% |
41,400
+3,400
| +9% | +$2.6K |
|
3086
eHealth
EHTH
$31.3M
| $24.1K | ﹤0.01% |
16,200
-8,900
| -35% | -$14.9K |
|
3087
Singularity Future Technology
SGLY
$8.54M
| $21.9K | ﹤0.01% |
+5,211
| New | +$29.5K |
|
3088
LiveWire
LVWR
$253M
| $21.5K | ﹤0.01% |
+19,197
| New | +$28.9K |
|
3089
CollPlant Biotechnologies
CLGN
$6.77M
| $21.5K | ﹤0.01% |
6,150
+4,470
| +266% | +$17.2K |
|
3090
Scienjoy Holding
SJ
$33.9M
| $21.5K | ﹤0.01% |
27,504
-500
| -2% | -$556 |
|
3091
Research Frontiers
REFR
$13.8M
| $21.2K | ﹤0.01% |
40,789
-27,511
| -40% | -$22.1K |
|
3092
Freightos
CRGO
$65.6M
| $20.1K | ﹤0.01% |
+13,200
| New | +$24.1K |
|
|
MOGU
3093
MOGU Inc
MOGU
$15.7M
| $19.8K | ﹤0.01% |
11,857
-1,132
| -9% | -$2.44K |
|
|
VIVS
3094
VivoSim Labs
VIVS
$3.77M
| $19.8K | ﹤0.01% |
+18,500
| New | +$24.9K |
|
|
RNTX
3095
Rein Therapeutics
RNTX
$74.4M
| $19.8K | ﹤0.01% |
19,000
-5,500
| -22% | -$6.66K |
|
3096
BeyondSpring
BYSI
$25.5M
| $19.1K | ﹤0.01% |
10,900
-200
| -2% | -$323 |
|
3097
SurgePays
SURG
$4.09M
| $18.4K | ﹤0.01% |
50,900
+1,000
| +2% | +$553 |
|
3098
Cardiff Oncology
CRDF
$85.6M
| $18.1K | ﹤0.01% |
13,942
-87,311
| -86% | -$139K |
|
3099
Milestone Scientific
MLSS
$39M
| $18.1K | ﹤0.01% |
56,297
-26,200
| -32% | -$9.01K |
|
3100
Solarmax Technology
SMXT
$11.4M
| $17.5K | ﹤0.01% |
4,174
-616
| -13% | -$3.91K |
|
Similar funds
Renaissance Technologies's Q2 2026 Portfolio in Review
As of Q2 2026, Renaissance Technologies held 3,761 positions worth $72.6B, up 14% from $63.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2026 filing shows 548 new, 1,084 increased, 1,502 reduced and 621 closed positions. Its largest new stake was Amazon: 2,290,710 shares worth $546M. The largest sale was Micron Technology, an estimated $1.46B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2026 buy was Amazon: 2,290,710 shares worth $546M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q2 2026, an estimated $1.08B increase.
- Renaissance Technologies's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.46B.
- Renaissance Technologies fully exited Applovin in Q2 2026, selling an estimated $174M.
- Renaissance Technologies's ten largest holdings make up 12% of its $72.6B portfolio in Q2 2026.
- Renaissance Technologies opened 548 new positions and closed 621 in Q2 2026.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $72.6B.
Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.